0 0 0 0 0 01/04/2024 31/03/2025 2025-03-31 false false false false false false false true false false true false false false false false true false No description of principal activities is disclosed 2024-04-01 Sage Accounts Production 24.0 - FRS102_2024 xbrli:pure xbrli:shares iso4217:GBP 7566142 2024-04-01 2025-03-31 7566142 2025-03-31 7566142 2024-03-31 7566142 2023-04-01 2024-03-31 7566142 2024-03-31 7566142 2023-03-31 7566142 bus:RegisteredOffice 2024-04-01 2025-03-31 7566142 bus:LeadAgentIfApplicable 2024-04-01 2025-03-31 7566142 bus:Director2 2024-04-01 2025-03-31 7566142 bus:Director3 2024-04-01 2025-03-31 7566142 core:RetainedEarningsAccumulatedLosses 2023-04-01 2024-03-31 7566142 core:RetainedEarningsAccumulatedLosses 2024-04-01 2025-03-31 7566142 core:WithinOneYear 2025-03-31 7566142 core:WithinOneYear 2024-03-31 7566142 core:ShareCapital 2025-03-31 7566142 core:ShareCapital 2024-03-31 7566142 core:RetainedEarningsAccumulatedLosses 2025-03-31 7566142 core:RetainedEarningsAccumulatedLosses 2024-03-31 7566142 core:ShareCapital 2023-03-31 7566142 core:RetainedEarningsAccumulatedLosses 2023-03-31 7566142 core:PreviouslyStatedAmount core:ShareCapital 2025-03-31 7566142 core:CostValuation core:Non-currentFinancialInstruments 2025-03-31 7566142 core:Non-currentFinancialInstruments 2025-03-31 7566142 core:Non-currentFinancialInstruments 2024-03-31 7566142 bus:SmallEntities 2024-04-01 2025-03-31 7566142 bus:AuditExempt-NoAccountantsReport 2024-04-01 2025-03-31 7566142 bus:SmallCompaniesRegimeForAccounts 2024-04-01 2025-03-31 7566142 bus:PrivateLimitedCompanyLtd 2024-04-01 2025-03-31 7566142 bus:FullAccounts 2024-04-01 2025-03-31
Company registration number: 7566142
COMPOUND MANAGEMENT (UK) LIMITED
Unaudited financial statements
31 March 2025
COMPOUND MANAGEMENT (UK) LIMITED
Contents
Directors and other information
Directors report
Statement of financial position
Statement of changes in equity
Notes to the financial statements
COMPOUND MANAGEMENT (UK) LIMITED
Directors and other information
Directors Mr James Morris
Mr Arvind Makadia
Company number 7566142
Registered office First Floor
23 Beaumont Mews
London
W1G 6EN
Accountant Mak Plus Limited
9 Westfield Drive
Harrow
Middlesex
HA3 9EG
COMPOUND MANAGEMENT (UK) LIMITED
Directors report
Year ended 31 March 2025
The directors present their report and the unaudited financial statements of the company for the year ended 31 March 2025.
Directors
The directors who served the company during the year were as follows:
Mr James Morris
Mr Arvind Makadia
Small company provisions
This report has been prepared in accordance with the provisions applicable to companies entitled to the small companies exemption.
This report was approved by the board of directors on 14 November 2025 and signed on behalf of the board by:
Mr Arvind Makadia
Director
COMPOUND MANAGEMENT (UK) LIMITED
Statement of financial position
31 March 2025
2025 2024
Note £ £ £ £
Fixed assets
Investments 4 12,435 12,435
_______ _______
12,435 12,435
Current assets
Debtors 5 1 1
Cash at bank and in hand 71 71
_______ _______
72 72
Creditors: amounts falling due
within one year 6 ( 12,535) ( 12,535)
_______ _______
Net current liabilities ( 12,463) ( 12,463)
_______ _______
Total assets less current liabilities ( 28) ( 28)
_______ _______
Net liabilities ( 28) ( 28)
_______ _______
Capital and reserves
Called up share capital 1 1
Profit and loss account ( 29) ( 29)
_______ _______
Shareholders deficit ( 28) ( 28)
_______ _______
For the year ending 31 March 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
Directors responsibilities:
- The members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476;
- The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of financial statements.
These financial statements have been prepared in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with Section 1A of FRS 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland'.
These financial statements were approved by the board of directors and authorised for issue on 14 November 2025 , and are signed on behalf of the board by:
Mr Arvind Makadia
Director
Company registration number: 7566142
COMPOUND MANAGEMENT (UK) LIMITED
Statement of changes in equity
Year ended 31 March 2025
Called up share capital Profit and loss account Total
£ £ £
At 1 April 2023 1 ( 29) ( 28)
Profit for the year - -
_______ _______ _______
Total comprehensive income for the year - - -
_______ _______ _______
At 31 March 2024 and 1 April 2024 1 ( 29) ( 28)
Profit for the year - -
_______ _______ _______
Total comprehensive income for the year - - -
_______ _______ _______
At 31 March 2025 1 ( 29) ( 28)
_______ _______ _______
COMPOUND MANAGEMENT (UK) LIMITED
Notes to the financial statements
Year ended 31 March 2025
1. General information
The company is a private company limited by shares, registered in England & Wales. The address of the registered office is First Floor, 23 Beaumont Mews, London, W1G 6EN.
2. Statement of compliance
These financial statements have been prepared in compliance with the provisions of FRS 102, Section 1A, 'The Financial Reporting Standard applicable in the UK and Republic of Ireland'.
3. Accounting policies
Basis of preparation
The financial statements have been prepared on the historical cost basis, as modified by the revaluation of certain financial assets and liabilities and investment properties measured at fair value through profit or loss.
The financial statements are prepared in sterling, which is the functional currency of the entity.
Taxation
The taxation expense represents the aggregate amount of current and deferred tax recognised in the reporting period. Tax is recognised in the statement of comprehensive income, except to the extent that it relates to items recognised in other comprehensive income or directly in capital and reserves. In this case, tax is recognised in other comprehensive income or directly in capital and reserves, respectively. Current tax is recognised on taxable profit for the current and past periods. Current tax is measured at the amounts of tax expected to pay or recover using the tax rates and laws that have been enacted or substantively enacted at the reporting date.
Deferred tax is recognised in respect of all timing differences at the reporting date. Unrelieved tax losses and other deferred tax assets are recognised to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Deferred tax is measured using the tax rates and laws that have been enacted or substantively enacted by the reporting date that are expected to apply to the reversal of the timing difference.
Fixed asset investments
Fixed asset investments are initially recorded at cost, and subsequently stated at cost less any accumulated impairment losses. Listed investments are measured at fair value with changes in fair value being recognised in profit or loss.
Impairment
A review for indicators of impairment is carried out at each reporting date, with the recoverable amount being estimated where such indicators exist. Where the carrying value exceeds the recoverable amount, the asset is impaired accordingly. Prior impairments are also reviewed for possible reversal at each reporting date. When it is not possible to estimate the recoverable amount of an individual asset, an estimate is made of the recoverable amount of the cash-generating unit to which the asset belongs. The cash-generating unit is the smallest identifiable group of assets that includes the asset and generates cash inflows that are largely independent of the cash inflows from other assets or groups of assets.
Financial instruments
A financial asset or a financial liability is recognised only when the company becomes a party to the contractual provisions of the instrument. Basic financial instruments are initially recognised at the transaction price, unless the arrangement constitutes a financing transaction, where it is recognised at the present value of the future payments discounted at a market rate of interest for a similar debt instrument. Debt instruments are subsequently measured at amortised cost. Where investments in non-convertible preference shares and non-puttable ordinary shares or preference shares are publicly traded or their fair value can otherwise be measured reliably, the investment is subsequently measured at fair value with changes in fair value recognised in profit or loss. All other such investments are subsequently measured at cost less impairment. Other financial instruments, including derivatives, are initially recognised at fair value, unless payment for an asset is deferred beyond normal business terms or financed at a rate of interest that is not a market rate, in which case the asset is measured at the present value of the future payments discounted at a market rate of interest for a similar debt instrument. Other financial instruments are subsequently measured at fair value, with any changes recognised in profit or loss, with the exception of hedging instruments in a designated hedging relationship.
Financial assets that are measured at cost or amortised cost are reviewed for objective evidence of impairment at the end of each reporting date. If there is objective evidence of impairment, an impairment loss is recognised in profit or loss immediately. For all equity instruments regardless of significance, and other financial assets that are individually significant, these are assessed individually for impairment. Other financial assets or either assessed individually or grouped on the basis of similar credit risk characteristics. Any reversals of impairment are recognised in profit or loss immediately, to the extent that the reversal does not result in a carrying amount of the financial asset that exceeds what the carrying amount would have been had the impairment not previously been recognised.
4. Investments
Other investments other than loans Total
£ £
Cost
At 1 April 2024 and 31 March 2025 12,435 12,435
_______ _______
Impairment
At 1 April 2024 and 31 March 2025 - -
_______ _______
Carrying amount
At 31 March 2025 12,435 12,435
_______ _______
At 31 March 2024 12,435 12,435
_______ _______
5. Debtors
2025 2024
£ £
Other debtors 1 1
_______ _______
6. Creditors: amounts falling due within one year
2025 2024
£ £
Other creditors 12,535 12,535
_______ _______